Navigation Links
RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
Date:12/1/2011

REDWOOD CITY, Calif., Dec. 1, 2011 /PRNewswire/ -- Clinical Investigators for Arstasis, Inc., reported the results of the RECITAL study during the recent TCT Meeting in San Francisco, demonstrating the Arstasis access device enables rapid, secure, implant-free closure of femoral arteries after cardiac catheterization procedures. The device creates a unique access pathway, called an Arstaotomy, into the femoral artery through which catheterization procedures are performed.

RECITAL is a prospective, multi-center clinical study that enrolled 351 patients to assess device and procedural success of key post-catheterization recovery measures that influence the safety and speed toward discharging those patients from the hospital. The results indicate that hospitals may be able to both reduce current complication rates and eliminate costs from longer hospitalizations in this patient population.

Key results of the RECITAL study showed that device deployment was successful in 97% of RECITAL patients and femoral bleeding stopped after only 3 minutes for diagnostic angiogram patients and 5 minutes for anti-coagulated patients undergoing a percutaneous coronary intervention (PCI). Most of the patients were able to sit up within 15-30 minutes and were able to walk in about one hour after an angiogram and two hours after a PCI. Investigators found no major complications related to use of the Arstasis device.

Dr. Dale Wortham, University of Tennessee  Medical Center, Knoxville and RECITAL Study Principal Investigator, commented, "Introducing foreign materials in a patient to close the femoral artery can be problematic. We were very pleased the RECITAL Study demonstrated the Arstaotomy procedure can deliver closure-like hemostasis and ambulation times without the use of a temporary or permanent implant."

The RECITAL Study illustrates the Arstaotomy procedure can potentially accelerate patient throughput, delivering a quicker, m
'/>"/>

SOURCE Arstasis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
2. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
4. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
5. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
6. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
7. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
8. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
9. Perceptive Informatics® Global Survey Results Indicate Wide Use of Industry-Standard Medical Imaging Metrics to Meet Study Milestones
10. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
11. goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... -- A groundbreaking new, minimally invasive outpatient treatment option ... is now readily available to the estimated 1 million ... who suffer from this condition. ... leading practitioner of this safe, effective, Federal Drug Administration-approved ... new Los Angeles -area medical centers ...
(Date:4/21/2015)... 2015 Oxfordshire ... more than doubled its overseas sales in just 4 ... winning the Queen,s Award for Enterprise, for Outstanding Achievement ... first HealthScience Communications consultancy, helping its clients bring new ... Having more than doubled its exports in just 4 ...
(Date:4/21/2015)... Cardiologists at Henry Ford Hospital have implanted a ... an irregular heartbeat. With only handful of hospitals ... is able to add another option to its arsenal of ... heart,s ability to pump. "This is a ... Watchman implant at a non-clinical trial site," says cardiologist ...
Breaking Medicine Technology:New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 2New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 4Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3
(Date:4/21/2015)... 2015 My Patriot Supply is proud ... latest innovation in home water filtration: Alexapure Pro™ ... that makes existing gravity-fed filters obsolete. An unprecedented advancement ... industry standards for water filtration. With an optimized flow ... typical household. , The Alexapure Pro™ takes a unique, ...
(Date:4/21/2015)... Sinking Spring, PA (PRWEB) April 21, 2015 ... neighboring Berks County commercial printer, Offset Impressions. ... with its full line of printing capabilities and knowledgeable ... Grafika. “This acquisition allows us to offer an ... addition to the labeling, packaging, and specialty services we ...
(Date:4/21/2015)... The California Healthcare Institute (CHI), ... sciences organizations, released the following statement by CHI ... Assembly Bill (AB) 463: , “As innovators in ... of treatments and cures for patients with serious ... AB 463, the so-called Pharmaceutical Cost Transparency Act ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Information is the ... Kevin Ryan, MD, FACP, empowers patients and their families with ... is the Rumor and Cancer is the Answer" and ... and informative language to guide patients from diagnosis through treatment ... patients active participants in their treatment, at home and in ...
(Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
Breaking Medicine News(10 mins):Health News:Preparedness Leader My Patriot Supply Unveils the New Alexapure Pro™ Water Filter 2Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... Sept. 30 Heartland Information Services, a national provider ... Himes to President and Chief Executive Officer. Previously Chief ... the President and CEO position immediately. , Himes will ... who has accepted a new position with Reichert, Inc. ...
... NEW YORK (Sept. 30, 2009) -- New research by ... ways parents and peers influence teenagers to smoke, drink ... toward smoking influenced teenagers, use of multiple drugs (smoking, ... in boys and girls. For girls, friends were ...
... system made of billions of neurons and thousands of ... of the strongest emotions, fear. Most neurological fear studies ... Missouri researchers have started using computational models of the ... Guoshi Li, an electrical and computer engineering doctoral student, ...
... a third of U.S. victims were also infected with pneumococcus ... News) -- Bacterial co-infections are common among people who have ... probably contributed to their deaths, according to a new federal ... Control and Prevention analyzed lung tissue samples from 77 people ...
... U.S. Food and Drug Administration today announced the availability ... Evaluation and Mitigation Strategies or REMS, which are required ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , The Food and Drug ... the authority to require the submission and implementation of ...
... ARLINGTON, Va. and BOSTON, Sept. 30 On November 16, ... GO! and Boston creative group CloudKid, invite early elementary school ... and friends in FIZZY,S LUNCH LAB ( PBSKIDSGO.org/lunchlab ... good and bad food, and learn what happens once the ...
Cached Medicine News:Health News:Heartland Information Services Appoints New Chief Executive Officer 2Health News:Teen attitudes toward smoking linked to likelihood of drinking and using drugs 2Health News:Researchers use computational models to study fear 2Health News:CDC Links Infections With Swine Flu Deaths 2Health News:CDC Links Infections With Swine Flu Deaths 3Health News:FDA Issues Draft Guidance on Risk Evaluation and Mitigation Strategies 2Health News:Video: Laughter is the Key Ingredient in 'FIZZY'S LUNCH LAB,' a New Health-Themed Web-Only Property Launching November 16 on PBSKIDSGO.org 2Health News:Video: Laughter is the Key Ingredient in 'FIZZY'S LUNCH LAB,' a New Health-Themed Web-Only Property Launching November 16 on PBSKIDSGO.org 3Health News:Video: Laughter is the Key Ingredient in 'FIZZY'S LUNCH LAB,' a New Health-Themed Web-Only Property Launching November 16 on PBSKIDSGO.org 4Health News:Video: Laughter is the Key Ingredient in 'FIZZY'S LUNCH LAB,' a New Health-Themed Web-Only Property Launching November 16 on PBSKIDSGO.org 5Health News:Video: Laughter is the Key Ingredient in 'FIZZY'S LUNCH LAB,' a New Health-Themed Web-Only Property Launching November 16 on PBSKIDSGO.org 6
... has been approved for use as an ... seizures in adults and adolescents over 12 ... that are refractory to antiepileptic medications. This ... controlled, clinical trials. Efficacy, measured as median ...
... Electrodes share similar characteristics with ... difference is that all of ... to assist you intraoperatively. In ... for use with either our ...
State-of-the-art sleep recording and analysis...
... workstation is a medical device designed to ... video capability, and archiving demands of the ... A framework that helps organize workflow and ... A centralized database and powerful search capability ...
Medicine Products: